Advertisement

Journal of Immigrant and Minority Health

, Volume 17, Issue 1, pp 76–78 | Cite as

Prevalence of Hepatitis B and C Viruses Among Asylum Seekers in Izmir

  • Şükran Köse
  • Lütfiye KuzucuEmail author
  • Ayhan Gözaydın
  • Tanju Yılmazer
Original Paper

Abstract

Hepatitis B and C virus infections are known to be an important health problem all over the World. According to the data from World Health Organization, 350 million people are estimated to have been chronically infected by hepatitis B virus and 180 million people have been infected by hepatitis C virus. Most of the patients are not aware of their illnesses. Hepatitis B and C virus infections are the most common cause of sequel liver disease related to decompensate liver cirrhosis and hepatocellular carcinoma. Many people are obliged to leave their country due to political, economic and social reasons. In Turkey, where there is refugee and asylum seeker problem because of geographical location, we aimed to specify the demographic characteristics of asylum seekers in Izmir and to evaluate the asylum seekers in terms of blood-borne and sexually transmitted diseases such as hepatitis B and C.

Keywords

Hepatitis B Hepatitis C Refugee Asylum seeker 

References

  1. 1.
    Saltoglu N. Treatment and alternative treatments in chronic hepatitis C patients who are nonresponsive to previous treatment/relapse. In: Tabak F, Balık İ, editors. Viral hepatitis. Istanbul: Istanbul Medical Press; 2009. p. 139–150.Google Scholar
  2. 2.
    Rein DB, Lesesne SB, O’Fallon A, Weinbaum CM. Prevalence of hepatitis B surface antigen among refugees entering the United States between 2006 and 2008. Hepatology. 2010;51(2):431–4.PubMedCrossRefGoogle Scholar
  3. 3.
    World Health Organization. Immunization, vaccines and biologicals, hepatitis B. 2008. Available at: http://www.who.int/immunization/topics/hepatitis_b/en/index.html. Accessed 11 Nov 2008.
  4. 4.
    Pehlivanoglu F, Yasar KK, Şengöz G. Asylum seekers: is there a need for new approaches to health problems? Nobel Med. 2011;7(1):102–5.Google Scholar
  5. 5.
    Ekşi N. Refugees, Asylum seekers, Immigrants. “Conference on Refugees, Asylum seekers, Immigrants”. University of Kocaeli Faculty of Law, 18 Nisan 2007.Google Scholar
  6. 6.
    Mahoney FJ, Kane M. Hepatitis B vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines, 3rd ed. Philadelphia: WB Saunders Company; 1999. p. 158–182.Google Scholar
  7. 7.
    Hollinger FB, Liang TJ. Hepatitis B virus. In: Knipe DM et al., editors. Field virology, 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 2971–3036.Google Scholar
  8. 8.
    Rantala M, van de Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe-a review. Euro Surveill. 2008;13(21). pii:18880.Google Scholar
  9. 9.
    Quer J, Estaban J. Epidemiology. In: Thomas HC, Lemon S, Zuckerman A, editors. Viral hepatitis, Massachusetts, USA. 3rd ed. Blackwell Publishing; 2005. p. 407–425.Google Scholar
  10. 10.
    Sunbul M. Epidemiology and protection of HCV infections. In: Tabak F, Balık İ, Tekeli E, editors. Viral Hepatitis Istanbul: VHSD; 2007. p. 208–19.Google Scholar
  11. 11.
    Tosun S. Change of epidemiology in hepatitis in our country. Book of 10. National Congress of Viral Hepatitis 01-04 Nisan 2010. 35–43.Google Scholar
  12. 12.
    Roussos A, Goritsas C, Pappas T, et al. Prevalence of hepatitis B and C markers among refugees in Athens. World J Gastroenterol. 2003;9(5):993–5.PubMedGoogle Scholar
  13. 13.
    Ugwu C, Varkey P, Bagniewski S, Lesnick T. Sero-epidemiology of hepatitis B among new refugees to Minnesota. J Immigr Minor Health. 2008;10(5):469–74.PubMedCrossRefGoogle Scholar
  14. 14.
    Museru OI, Vargas M, Kinyua M, Alexander KT, Paredes CF, Oladele A. Hepatitis B virus infection among refugees resettled in the US: high prevalence and challenges in access to health care. J Immigr Minor Health. 2010;12:823–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5:558–67.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Şükran Köse
    • 1
  • Lütfiye Kuzucu
    • 1
    Email author
  • Ayhan Gözaydın
    • 2
  • Tanju Yılmazer
    • 3
  1. 1.Infectious Diseases and Clinical MicrobiologyTepecik Education and Research HospitalIzmirTurkey
  2. 2.Infectious Diseases and Clinical MicrobiologyPrivate Hospital of Medi-tech FatsaOrduTurkey
  3. 3.Department of Family MedicineTepecik Education and Research HospitalIzmirTurkey

Personalised recommendations